Epithelial TGFß engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. (2022)
Attributed to:
Examining the relationship between KRAS mutation and immunotherapy resistance in colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-35134-3
PubMed Identifier: 36477656
Publication URI: http://europepmc.org/abstract/MED/36477656
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723